Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
about
HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the StomachChemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression.A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer.Tracheal dysplasia precedes bronchial dysplasia in mouse model of N-nitroso trischloroethylurea induced squamous cell lung cancer.HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study.Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas.HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumorsProliferative changes in the bronchial epithelium of former smokers treated with retinoids.Vitamin D Repletion Reduces the Progression of Premalignant Squamous Lesions in the NTCU Lung Squamous Cell Carcinoma Mouse Model.Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma.Lung cancer screening update.Thymidylate synthase protein expression by IHC and gene copy number by SISH correlate and show great variability in non-small cell lung cancer.Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells.The field of tissue injury in the lung and airway.Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer.Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.Aberrant Signaling through the HER2-ERK1/2 Pathway is Predictive of Reduced Disease-Free and Overall Survival in Early Stage Non-Small Cell Lung Cancer (NSCLC) Patients.Reproducibility of the EGFR immunohistochemistry scores for tumor samples from patients with advanced non-small cell lung cancerTargeting and delivery of platinum-based anticancer drugs.Oral field cancerization: an update on current concepts.Positional isomerization of a non-cleavable combi-molecule dramatically altered tumor cell response profile.Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles.Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms.Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.Monoglyceride lipase gene knockout in mice leads to increased incidence of lung adenocarcinoma.HPV-Induced Field Cancerisation: Transformation of Adult Tissue Stem Cell Into Cancer Stem Cell.EGFR overexpression in canine primary lung cancer: pathogenetic implications and impact on survival.Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells.
P2860
Q26780318-0224BEF0-3A83-48A9-B1B0-82C7B95C5C2FQ34994448-39419D99-EB7F-482B-8A3E-D57A2AD8D6E0Q35010602-CEECB9CC-9590-4F55-9FCF-9269502715ECQ35364691-B78F44BC-322F-49C5-9071-82238C3B76DDQ35893399-D47AA984-8F82-489F-9955-7C13F5A17FABQ36014004-B7982E0F-3981-4727-8AD2-DB5F077A8119Q36025680-3768E3F8-C56B-4D68-AB7D-B8C3005C6BA9Q36231743-14D0B4E4-7DA4-4D70-B9CC-83097EB58268Q36332442-FD242497-1CF6-48CD-A324-E7D1B0E9D863Q36358309-CF7043FA-64A7-4369-B98F-1A4ED88A8181Q36446587-3D758758-8D45-413D-9D38-175FA0E87AD3Q36754898-A181660E-338E-4938-9F47-82A34F9A03BCQ36821180-32917759-6249-4A5C-B18D-ABB981A86359Q37218007-EC229AEB-D253-46C3-B06E-22BEF5E496C3Q37250499-391F40A6-CCA8-4D07-812E-501D758AE4DBQ37579647-9953E500-1E40-4D3C-A1CD-4FC346EC534FQ37628928-2AA4C765-3677-4ED2-8F1F-BFE22F653F25Q37667783-B798DD66-5B7C-40E5-B943-4F4C2CEF57D9Q37701159-AC1D3CDD-7D1B-4092-9975-11BEB7385B51Q38050063-664E6677-FAF5-4876-BC86-49CB059DBDECQ38493190-176F885F-C365-46C5-9617-1EC42047D130Q38968743-6FC2461A-88D1-44A6-9BCE-846722608231Q39451814-F981C4BA-6421-4C81-91AD-F98F6D107AA6Q47130146-4D7885F3-D9D7-49D7-922B-67FD6736AFD8Q47739176-5EAE83BB-A851-4F88-8617-1379DD5E7F9DQ49952999-0F9BE845-2823-4BDF-97BD-1B49C11E45C5Q52597650-647FC6E2-C5C8-4540-8496-1547F00CF681Q53264287-9C402521-D1D5-4B8D-B702-C048498C3308Q54976478-35A5C8FB-C416-4785-8583-99F8ED2BBEC2
P2860
Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Analysis of c-ErbB1/epidermal ...... hemoprevention of lung cancer.
@ast
Analysis of c-ErbB1/epidermal ...... hemoprevention of lung cancer.
@en
type
label
Analysis of c-ErbB1/epidermal ...... hemoprevention of lung cancer.
@ast
Analysis of c-ErbB1/epidermal ...... hemoprevention of lung cancer.
@en
prefLabel
Analysis of c-ErbB1/epidermal ...... hemoprevention of lung cancer.
@ast
Analysis of c-ErbB1/epidermal ...... hemoprevention of lung cancer.
@en
P2093
P1476
Analysis of c-ErbB1/epidermal ...... hemoprevention of lung cancer.
@en
P2093
Daniel T Merrick
Fred R Hirsch
Georgia Kotantoulas
John Kittelson
Ralph Winterhalder
Robert L Keith
Steen Ingeberg
Timothy C Kennedy
Wilbur A Franklin
York E Miller
P304
P356
10.1158/1078-0432.CCR-05-2291
P407
P433
P577
2006-04-01T00:00:00Z